Effect of human lactoferrin solution on histological changes of rabbit cornea in alkaline burns

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: Eye burns are a severe injury, accounting for 6.1–38.4% of all ophthalmic diseases. Alkaline burns are the most common and most severe forms of eye burns.

AIM: Evaluation of the effectiveness of drug topical application based on human lactoferrin in alkaline cornea burns of the 3rd degree in the experiment.

MATERIAL AND METHODS: The study was conducted on 42 rabbits. It included two groups: the first (without treatment) — alkaline burns during therapy with water for injection (1 drop 3 times a day) — 21 rabbits, the second (experimental) — treatment with lactoferrin solution (concentration 2.5 mg/ml, 1 drop 3 times a day) — 21 rabbits. Alkaline burns were induced by applying a filter paper disc moistened with 5% sodium hydroxide solution to the cornea. 6 eyes of 3 intact animals served as controls. The effectiveness of the drug was evaluated by the rate of closure of the corneal epithelium defect, the time of suppression of the inflammatory reaction in the area of the defect and the limbus, the degree of restoration of the morphological structure of the cornea, as close as possible to the normal rabbit cornea. The obtained data were processed using the methods of variation statistics, the Statistica 10.0 software package. The significance of differences was assessed by calculating the median and interquartile interval. The critical level of significance for statistical criteria was taken as p=0.05.

RESULTS: From the 3rd day of the study, in the experimental treatment group, there was an acceleration of reepithelialization, restoration of the cornea's own substance, and a more rapid subsidence of inflammation compared to the control group. The thickness of the cornea in the center of the defect in the group without treatment was significantly higher than the values of intact animals at all periods of observation: on the 3rd day after the burn it was 615.99 [450.70–794.07] µm (p=0.000574), reached the maximum by day 7 — it was 1363.16 [907.78–1543.44] µm (p=0.000091), and by day 28 it decreased to 384.38 [376.03–398.14] µm (p=0.0000041). In the group with experimental treatment, the thickness of the cornea in the center of the defect also increased relative to intact animals, starting from the 1st day of pathology, reaching maximum values on the 3rd day — 436.70 [415.57–489.90] µm (p=0.005589). The use of lactoferrin solution in comparison with the first group led to a significant decrease in the thickness of the cornea in the center of the defect on 7th (p=0.039985) and 28th days (p=0.0443).

CONCLUSION: Local application of lactoferrin solution in alkaline burns of the cornea promotes faster regeneration of the epithelium and restoration of the stroma structure of the rabbit cornea.

Full Text

Restricted Access

About the authors

Alexander V. Kolesnikov

Ryazan State Medical University named after I.P. Pavlov

Email: kolldoc@mail.ru
ORCID iD: 0000-0001-9025-5258

M.D., D. Sci. (Med.), Head of Depart., Depart. of Eye Diseases

Russian Federation, Ryazan, Russia

Elena R. Nemtsova

Moscow Research Institute of Oncology named after P.A. Herzen — branch of the National Research Center for Radiology

Email: nemtz@yandex.ru
ORCID iD: 0000-0002-3579-1733

D. Sci. (Biol.), Leading Researcher, Depart. of Experimental Phtharmacology and Toxico­logy

Russian Federation, Moscow, Russia

Tatyana M. Cherdantseva

Ryazan State Medical University named after I.P. Pavlov

Email: cherdan.morf@yandex.ru
ORCID iD: 0000-0002-7292-4996
SPIN-code: 3773-8785
Scopus Author ID: 54880998200

M.D., D. Sci. (Med.), Assoc. Prof., Head of Depart., Depart. of Histology, Patholo­gical Anatomy and Medical Genetics

Russian Federation, Ryazan, Russia

Irina V. Kirsanova

Ryazan State Medical University named after I.P. Pavlov

Email: kirsanova-iv@inbox.ru
ORCID iD: 0000-0002-2851-0972

Postgrad. Stud., Depart. of Eye Diseases

Russian Federation, Ryazan, Russia

Tatyana D. Kislyakova

North-Western State Medical University named after I.I. Mechnikov

Author for correspondence.
Email: grishn98@yandex.ru
ORCID iD: 0000-0002-1733-9671
SPIN-code: 4113-5830

Clinical Resident, Depart. of Ophthalmology

Russian Federation, St. Petersburg, Russia

References

  1. Munz IV, Direev AO, Gusarevitch OG, Scherbakova LV, Mazdorova EV, Malyutina SK. Prevalence of ophthalmic diseases in the population older than 50 years. Annals of ophthalmology. 2020;136(3):106-115. (In Russ.) doi: 10.17116/oftalma2020136031106.
  2. Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: A literature review. Ophthalmic Res. 2012;47:171–188. doi: 10.1159/000329603.
  3. Kanyukov VN, Stadnikov AA, Trubina OM, Raxmatullin RR, Yaxina OM. Gistoekvivalent bioplasticheskogo materiala v oftal`mologii. (Histoequivalent of bioplastic material in ophthalmology.) Orenburg: Dom pechati — Vyatka; 2014. 174 р. (In Russ.)
  4. Puchkovskaya NA, Yakimenko SA, Nepomnyashchaya VM. Ozhogi glaz. (Eye burns.) M.: Meditsina; 2001. 271 р. (In Russ.)
  5. Puchkovskaya NA, Shul'gina NS, Nepomnyashchaya VM. Patogenez i lecheniye ozhogov glaz i ikh posledstviy. (Pathogenesis and treatment of eye burns and their consequences.) M.: Meditsina; 1983. 207 р. (In Russ.)
  6. Thoft RA, Friend J. The XYZ hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci. 1983;24:1442–1443. PMID: 6618809.
  7. Pellegrini G, Golisano O, Paterna P. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol. 1999;145(4):769–782. doi: 10.1083/jcb.145.4.769.
  8. Anderson DF, Ellies P, Pires RTF, Tseng SCG. Amniotic membrane trans-plantation for partial limbal stem cell deficiency. Br J Ophthalmol. 2001;85:567–575. doi: 10.1136/bjo.85.5.567.
  9. Chernysh VF, Boyko EV Ozhogi glaz. Sostoyaniye problemy i novyye podkhody. 2-e izd., pererab. i dop. (Eye burns. State of the problem and new approaches. 2nd ed., revised and enlarged.) M.: GЕOTAR-Media; 2017. 184 р. (In Russ.)
  10. Fujisawa K, Katakami C, Yamamoto M. Keratocyte activity during wound healing of alkali-burned cornea. Nippon Ganka Gakkai Zasshi. 1991;95:59–66. PMID: 2042530.
  11. Shul’gina NS. The role of impaired immunobiological systems in the pathogenesis of corneal burns. Oftalmologicheskiy zhurnal. 1959;(6):323–327. (In Russ.)
  12. Davanger M, Evensen A. Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature. 1971;229:560–561. doi: 10.1038/229560a0.
  13. Filippova EO, Krivosheina OI. Effectiveness of ion-exchange eye lens in the treatment of cornea and conjunctiva acid burn (experimental study). Bashkortostan medical newsletter. 2017;(2):119–121. (In Russ.)
  14. Kruzel ML, Zimecki M, Actor JK. Lactoferrin in a context of inflammation-induced pathology. Front Immunol. 2017;8:1438. doi: 10.3389/fimmu.2017.01438.
  15. Ochirova EK, Plekhanov AN. Medicamentous treatment of eye burns (literature review). Acta Biomedica Scientifica. 2010;(3):364–369. (In Russ.)
  16. Brodsky IB, Bondarenko VM, Tomashevskaya NN, Sadchikova ER, Goldman IL. Antimicrobial, immunomodulatory and prebiotic properties of lactoferrin. Byulleten Orenburgskogo nauchnogo tsentra UrO RAN. 2013;(4):45–48. (In Russ.)
  17. Gabdrakhmanova AF, Meshcheryakova SA, Gaynutdinova RF. Experimental study of the effectiveness of 6-methyl-3-(thietane-3-yl)uracil-containing eye ointment in the treatment of corneal thermal burns. Kazan medical journal. 2019;100(4):657–661. (In Russ.) doi: 10.17816/KMJ2019-657.
  18. Lönnerdal B, Iyer S. Lactoferrin: Molecular structure and biological function. Annu Rev Nutr. 1995;15:93–110. doi: 10.1146/annurev.nu.15.070195.000521.
  19. Fine DH, Toruner GA, Velliyagounder K, Sampathkumar V, Godboley D, Furgang D. A lactotransferrin single nucleotide polymorphism demonstrates biological activity that can reduce susceptibility to caries. Infect Immun. 2013;81(5):1596–1605. doi: 10.1128/IAI.01063-12.
  20. Elass-Rochard E, Legrand D, Salmon V, Roseanu A, Trif M, Tobias PS, Mazurier J, Spik G. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun. 1998;66(2):486–491. doi: 10.1128/IAI.66.2.486-491.1998.
  21. Clinical guidelines. Eye burns. All-Russian public organization “Association of ophthalmologists”. http://avo-portal.ru/doc/fkr/item/254-ozhogi-glaz (access date: 03.02.2023). (In Russ.)
  22. Oksibuprokain (Oxibuprocaine). Instructions for the medical use of the drug. Register of medicines of Russia. https://www.rlsnet.ru/drugs/oksibuprokain-79740 (access date: 07.01.2023). (In Russ.)
  23. Obenberger J. Paper strips and rings as simple tools for standartization of experimental eye injuries. Ophthalmol Res. 1975;7:363–366. doi: 10.1159/000264772.
  24. Ballow M, Donshik PC, Rapacz P, Samartino L. Tear lactoferrin levels in patients with external inflammatory ocular disease. Invest Ophthalmol Vis Sci. 1987;28(3):543–545. PMID: 3030955.
  25. Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin. Biochimie. 2009;91(1):19–29. doi: 10.1016/j.biochi.2008.05.015.
  26. Williams TJ, Schneider RP, Willcox MD. The effect of protein-coated contact lenses on the adhesion and viability of gramnegative bacteria. Curr Eye Res. 2003;27(4):227–235. doi: 10.1076/ceyr.27.4.227.16602.
  27. Kolesnikov AV, Shchulkin AV, Barenina OI, Yakubovskaya RI, Nemtsova ER, Pankratov AA, Shmarov MM, Ataullakhanov RR. Method for the treatment of purulent corneal ulcer. Rossiyskaya oftalmologiya online. 2017;(24):41. (In Russ.)
  28. Ashby B, Garrett Q, Willcox M. Bovine lactoferrin structures promoting corneal epithelial wound healing in vitro. Invest Ophthalmol Vis Sci. 2011;52:2719–2726. doi: 10.1167/iovs.10-6352.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Рис. 1. Картина щелочного ожога на 1-е сутки эксперимента, центр дефекта: А — лечение плацебо; Б — лечение раствором лактоферрина 2,5 мг/мл. Окраска гематоксилином и эозином, увеличение ×200

Download (73KB)
Indexing metadata
3. Рис. 2. Картина щелочного ожога на 3-и сутки эксперимента, центр дефекта: А — лечение плацебо; Б — лечение раствором лактоферрина 2,5 мг/мл. Окраска гематоксилином и эозином, увеличение ×200

Download (65KB)
Indexing metadata
4. Рис. 3. Картина щелочного ожога на 7-е сутки эксперимента, центр дефекта: А — лечение плацебо; Б — лечение раствором лактоферрина 2,5 мг/мл. Окраска гематоксилином и эозином. А — увеличение ×40; Б — увеличение ×200

Download (62KB)
Indexing metadata
5. Рис. 4. Картина щелочного ожога на 28-е сутки эксперимента, центр дефекта: А — лечение плацебо; Б — лечение раствором лактоферрина 2,5 мг/мл. Окраска гематоксилином и эозином, увеличение ×200

Download (64KB)
Indexing metadata

© 2024 Eco-Vector